Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis

Background: The episode of acute decompensated heart failure (ADHF) is the main cause of hospitalization for heart failure (HF). Sacubitril–valsartan has been proven to be effective in reducing the risks of hospitalization for HF in ADHF. When to initiate sacubitril–valsartan in ADHF to make it the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Tianyang, Liu, Yiting, Lou, Yake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018029/
https://www.ncbi.nlm.nih.gov/pubmed/36937882
http://dx.doi.org/10.3389/fphar.2023.925375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018029/
https://www.ncbi.nlm.nih.gov/pubmed/36937882
http://dx.doi.org/10.3389/fphar.2023.925375

Ejemplares similares